Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
European Urology
|
August 1, 2025
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
Alessandro Larcher, Riccardo Campi, Axel Bex, et al.
European Urology
|
February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
Jens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
Applied Health Economics and Health Policy
|
July 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay, et al.
Trials
|
March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial
Diana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update
Axel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology
|
May 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
Umberto Capitanio, Patricia Zondervan, Riccardo Campi, et al.
The Journal of Pathology
|
April 16, 2015
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
Nelma Pertega-Gomes, Sergio Felisbino, Charlie E Massie, et al.
Plos One
|
February 3, 2012
Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts
Ruth E Schietke, Thomas Hackenbeck, Maxine Tran, et al.
BJR Case Reports
|
August 21, 2019
First-in-human <i>in vivo</i> non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma
Maxine Tran, Arash Latifoltojar, Joana B Neves, et al.
Nature Communications
|
September 25, 2023
Targetable NOTCH1 rearrangements in reninoma
Taryn D Treger, John E G Lawrence, Nathaniel D Anderson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
European Urology
|
August 1, 2025
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
Alessandro Larcher, Riccardo Campi, Axel Bex, et al.
European Urology
|
February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
Jens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
Applied Health Economics and Health Policy
|
July 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay, et al.
Trials
|
March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial
Diana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update
Axel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology
|
May 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
Umberto Capitanio, Patricia Zondervan, Riccardo Campi, et al.
The Journal of Pathology
|
April 16, 2015
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
Nelma Pertega-Gomes, Sergio Felisbino, Charlie E Massie, et al.
Plos One
|
February 3, 2012
Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts
Ruth E Schietke, Thomas Hackenbeck, Maxine Tran, et al.
BJR Case Reports
|
August 21, 2019
First-in-human <i>in vivo</i> non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma
Maxine Tran, Arash Latifoltojar, Joana B Neves, et al.
Nature Communications
|
September 25, 2023
Targetable NOTCH1 rearrangements in reninoma
Taryn D Treger, John E G Lawrence, Nathaniel D Anderson, et al.
Page
of 3